Evidence map›Paper›PMID 31311100›Full record

ArticleInternational journal of molecular sciences2019

Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway.

Md Moniruzzaman, Ran Wang, Varinder Jeet, Michael A McGuckin, Sumaira Z Hasnain

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. The role of IL-22 in cancer.Medical oncology (Northwood, London, England) · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. LRG1: an emerging player in disease pathogenesis.Journal of biomedical science · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Md MoniruzzamanFaculty of Medicine, The University of Queensland, Brisbane, QLD 4067, Australia.
Ran WangImmunopathology Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, QLD 4102, Australia.
Varinder JeetAustralian Prostate Cancer Research Centre-Queensland, Institute of Health Biomedical Innovation (IHBI), Queensland University of Technology, Brisbane, QLD 4102, Australia.
Michael A McGuckinFaculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, VIC 3052, Australia.
Sumaira Z HasnainFaculty of Medicine, The University of Queensland, Brisbane, QLD 4067, Australia. sumaira.hasnain@mater.uq.edu.au.
University of Queensland · AUMater Research · AUQueensland University of Technology · AUUniversity of Melbourne · AU

Funding

Australian Government Department of Education and Training Research Training Program ScholarshipGastroenterological Society of Australia Bushell Post‑doctoral Research Fellowship (R.W)Mater Foundation S.Z.H and R.WMater Research Frank Clair Scholarship (M. M)National Health and Medical Research Council Career Development Fellowship (S.Z.H)University of Queensland Centennial Scholarship (M. M)
6 · The paper itself

Abstract

The interleukin (IL)-20 subfamily of cytokines consists of IL-19, IL-20, IL-22, IL-24, and IL-26, and the expression of IL-20, IL-22, and IL-24 is reported to be higher in the colon of patients with ulcerative colitis. Although the receptors for these cytokines are highly expressed in the colon epithelium, their effects on epithelial renewal are not clearly understood. This study evaluated the effects of IL-20, IL-22, and IL-24 in epithelial renewal using the LS174T human colon cancer epithelial cell line. LS174T cells were treated with IL-20, IL-22, and IL-24 (25, 50, and 100 ng/mL) and a live-cell imaging system was used to evaluate the effects on cell proliferation. Following treatment, the signaling pathways contributing to cell proliferation were investigated through Western blotting in LS174T cells and downstream transcriptional changes through qRT-PCR in LS174T cells, and RNA-Seq in primary murine intestinal epithelial cells. Our results demonstrated that only IL-22 promoted LS174T cell proliferation, mediated via extracellular-signal-regulated kinase (ERK)1/2-mediated downstream regulation of p90RSK, c-Jun, and transcriptional changes of

Indexed as

Cell ProliferationMAP Kinase Signaling SystemAnimalsCell Line, TumorCells, CulturedColonic NeoplasmsEnterocytesHumansInterleukinsMiceMice, Inbred C57BLMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3InterleukinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3cell proliferationERK1/2IL-20IL-22IL-24wound healing

Identifiers

PMID31311100
PMCPMC6678670
OpenAlexW2962647820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.